Kalvista Pharmaceuticals Inc (KALV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 07-2019 | 04-2019 | 01-2019 | 10-2018 | 07-2018 | |
| Sales | 3,369 | 0 | 3,890 | 5,592 | 3,718 |
| Gross Profit | 3,369 | N/A | 3,890 | 5,592 | 3,718 |
| Operating Expenses | 12,933 | 0 | 10,550 | 10,485 | 10,727 |
| Operating Income | -9,564 | N/A | -6,660 | -4,893 | -7,009 |
| Other Income | 2,226 | 0 | 2,704 | 1,589 | 1,979 |
| Pre-tax Income | -7,338 | 0 | -3,956 | -3,304 | -5,030 |
| Net Income Continuous | -7,338 | N/A | -3,956 | -3,304 | -5,030 |
| Net Income | $-7,338 | $N/A | $-3,956 | $-3,304 | $-5,030 |
| EPS Basic Total Ops | -0.42 | N/A | -0.23 | -0.22 | -0.47 |
| EPS Basic Continuous Ops | -0.42 | N/A | -0.23 | -0.22 | -0.47 |
| EPS Diluted Total Ops | -0.42 | N/A | -0.23 | -0.22 | -0.47 |
| EPS Diluted Continuous Ops | -0.42 | N/A | -0.23 | -0.22 | -0.47 |
| EBITDA(a) | $-9,564 | $N/A | $-6,404 | $-4,764 | $-7,009 |